glp-1 mitochondria Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation The role of glucagon-like peptide-1/GLP-1R

Preclinical research shows that bitter compounds act through an extracellular odorant binding protein to inhibit sweet-responsive neurons and block the response to sweet taste, 9 making bitter herbs an important therapeutic tool in modifying dietary choices

The technology that could detect peptide drugs Detection of peptide drugs is technically feasible using: LC-MS/MS

Rosenstock et al

To meet the targets of 30 to 80 g of protein per reduced-size portion observed at Chipotle, isolates which offer high solubility and have a minimal impact on flavour and texture are technically preferable

GLP-1 drugs "represent a major breakthrough in obesity management," the researchers wrote in the study

Cell Metab 2006;4:391406.PubMed 35